Found: 18
Select item for more details and to access through your institution.
Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial.
- Published in:
- European Heart Journal, 2020, v. 41, n. 47, p. 4497, doi. 10.1093/eurheartj/ehaa617
- By:
- Publication type:
- Article
Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study.
- Published in:
- Thrombosis Journal, 2018, v. 16, n. 1, p. N.PAG, doi. 10.1186/s12959-018-0163-7
- By:
- Publication type:
- Article
Correction to: Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study.
- Published in:
- Thrombosis Journal, 2018, v. 16, n. 1, p. N.PAG, doi. 10.1186/s12959-018-0173-5
- By:
- Publication type:
- Article
Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study.
- Published in:
- Thrombosis Journal, 2018, v. 16, n. 1, p. N.PAG, doi. 10.1186/s12959-018-0163-7
- By:
- Publication type:
- Article
The management of acute venous thromboembolism in clinical practice -- study rationale and protocol of the European PREFER in VTE Registry.
- Published in:
- Thrombosis Journal, 2015, v. 13, p. 1, doi. 10.1186/s12959-015-0071-z
- By:
- Publication type:
- Article
Original Research: Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study.
- Published in:
- Therapeutic Advances in Cardiovascular Disease, 2007, v. 1, n. 2, p. 97, doi. 10.1177/1753944707085982
- By:
- Publication type:
- Article
Efficacy and Safety of Triple Antihypertensive Therapy with the Olmesartan/Amlodipine/Hydrochlorothiazide Combination.
- Published in:
- Clinical Drug Investigation, 2012, v. 32, n. 10, p. 649, doi. 10.1007/BF03261919
- By:
- Publication type:
- Article
The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective multicenter study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Adding Hydrochlorothiazide to Olmesartan/Amlodipine Increases Efficacy in Patients With Inadequate Blood Pressure Control on Dual-Combination Therapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Efficacy and tolerability of triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide: a subgroup analysis of patients stratified by hypertension severity, age, sex, and obesity.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Efficacy and Tolerability of Triple-Combination Therapy With Olmesartan, Amlodipine, and Hydrochlorothiazide: A Subgroup Analysis of Patients Stratified by Hypertension Severity, Age, Sex, and Obesity.
- Published in:
- Journal of Clinical Hypertension, 2014, v. 16, n. 10, p. 729, doi. 10.1111/jch.12408
- By:
- Publication type:
- Article
A prospective real‐world study of the diffuse‐type tenosynovial giant cell tumor patient journey: A 2‐year observational analysis.
- Published in:
- Journal of Surgical Oncology, 2022, v. 126, n. 8, p. 1520, doi. 10.1002/jso.27067
- By:
- Publication type:
- Article
Routine clinical practice in the periprocedural management of edoxaban therapy is associated with low risk of bleeding and thromboembolic complications: The prospective, observational, and multinational EMIT‐AF/VTE study.
- Published in:
- Clinical Cardiology, 2020, v. 43, n. 7, p. 769, doi. 10.1002/clc.23379
- By:
- Publication type:
- Article
The global Edoxaban Treatment in routine cliNical prActice (ETNA) noninterventional study program: rationale and design.
- Published in:
- Clinical Cardiology, 2019, v. 42, n. 12, p. 1147, doi. 10.1002/clc.23279
- By:
- Publication type:
- Article
Clinical risk predictors in atrial fibrillation patients following successful coronary stenting: ENTRUST-AF PCI sub-analysis.
- Published in:
- Clinical Research in Cardiology, 2021, v. 110, n. 6, p. 831, doi. 10.1007/s00392-020-01760-4
- By:
- Publication type:
- Article
Tenosynovial Giant Cell Tumor Observational Platform Project (TOPP) Registry: A 2-Year Analysis of Patient-Reported Outcomes and Treatment Strategies.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. e425, doi. 10.1093/oncolo/oyad011
- By:
- Publication type:
- Article
Open-Label Study Assessing the Long-term Efficacy and Safety of Triple Olmesartan/Amlodipine/Hydrochlorothiazide Combination Therapy for Hypertension.
- Published in:
- Advances in Therapy, 2014, v. 31, n. 5, p. 561, doi. 10.1007/s12325-014-0117-9
- By:
- Publication type:
- Article